Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality
Prospective analysis associating higher circulating DHA with lower all-cause mortality (~21% lower comparing highest vs lowest quintile).
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
Mayo Clinic Proceedings
Structured Methods
- Study Design
- Cohort Study
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (n.d.). Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality. Mayo Clinic Proceedings.
Source
Publisher
Journal
Mayo Clinic Proceedings
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
